Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2005, p. 3438-3442, Vol. 43, No. 7
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.7.3438-3442.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
David A. Bruckner,2 and
Andrew E. Simor3
Gen-Probe Incorporated, San Diego, California,1 UCLA Medical Center, Department of Pathology and Laboratory Medicine, Los Angeles, California,2 Sunnybrook and Women's College Health Sciences Centre, Department of Microbiology, Toronto, Canada3
Received 29 November 2004/ Returned for modification 24 January 2005/ Accepted 21 March 2005
rRNA gene sequences were used for identification and target adequacy controls in a DNA probe assay to identify isolates as Staphylococcus and, more specifically, as S. aureus within 1 hour. mecA status was simultaneously determined using a specific DNA probe. The target adequacy control guarded against false-negative mecA results.
Present address: Beth Israel Medical Center, New York, N.Y.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|